Furthermore, both type I and type II IFN signaling have been proven to be necessary for developing disease in the SjS-susceptible mouse model (SjSS) C57BL/6.NOD-Aec1Aec26,7. This evidence concerns the gene IFNA1 and Schwartz-Jampel syndrome.